Closing Capacity to Total Lung Capacity Ratio
ورودیهای بالینی بیمار
حداقل ۰.۳ — حداکثر ۶ • واحد: L
حداقل ۲ — حداکثر ۱۲ • واحد: L
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- calculated≥ 0
The Closing Capacity to Total Lung Capacity Ratio calculates stratifying pneumonia severity, respiratory failure progression, and inpatient admission requirements. Key inputs include closing capacity l. Scores guide determining appropriate admission level (floor versus ICU), tailoring antimicrobial therapy, and ventilatory support. Routine clinical application promotes standardized evidence-based patient management.
Clinical Guidelines & Evidence
CC/TLC ratio as percent.
Clinical Indication
The Closing Capacity to Total Lung Capacity Ratio is indicated for bedside clinical practice to support CC/TLC ratio as percent.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with community-acquired pneumonia, COPD exacerbations, acute asthma, pulmonary embolism, or acute respiratory distress. Clinical application is indicated across Respiratory care units, emergency pulmonary triage, sleep clinics, and medical floors.
Limitations & Contraindications
Peripheral pulse oximetry loses reliability in hypoperfusion, severe vasoconstriction, methemoglobinemia, or carboxyhemoglobinemia.
Clinical Pearls & Action Plan
Synchronous evaluation of arterial blood gas (PaO2/FiO2), mechanics of breathing, and clinical trajectory guides respiratory failure management.
CC/TLC x 100
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| closing_capacity_l | float | Yes | Closing capacity(L) |
| tlc_l | float | Yes | Total lung capacity(L) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| ≥ 0 | calculated | Calculated value |
Evidence-Based References (EBM)
- Anthonisen NR. Closing volume. In: Fishman's Pulmonary Diseases.